Covid 19 Vaccine

Welcome to Wondercafe2!

A community where we discuss, share, and have some fun together. Join today and become a part of it!

I get it via workplacce, even then codes were emailed out here which is a little more streamlined. Some issues, but that came mostly from those who had to gather lists of names/the places they got the info from of who should be getting them, some weren't up to date on things like people being on mat leave.
Actually another one here in London (and probably in other parts of the province): Adults (16+) who receive home care on a chronic (ie. ongoing) basis are going to be contacted by their home care provider.

Having worked for a few years providing IT support in that sector (my current job but my time was divided between the home oxygen company and the home care company), I can safely say that home care providers are probably scrambling to fulfill this. The one I worked for basically had enough coordinators to keep up with scheduling visits and calls from clients about problems and schedule changes, not to handle a major program like this. They would probably be dragooning case managers into doing the calling, but they are supposed to be out assessing clients and supervising new HSWs and PSWs, not sitting in the office making phone calls.
 
Actually another one here in London (and probably in other parts of the province): Adults (16+) who receive home care on a chronic (ie. ongoing) basis are going to be contacted by their home care provider.

Having worked for a few years providing IT support in that sector (my current job but my time was divided between the home oxygen company and the home care company), I can safely say that home care providers are probably scrambling to fulfill this. The one I worked for basically had enough coordinators to keep up with scheduling visits and calls from clients about problems and schedule changes, not to handle a major program like this. They would probably be dragooning case managers into doing the calling, but they are supposed to be out assessing clients and supervising new HSWs and PSWs, not sitting in the office making phone calls.
That makes sense. We still don't have details for medical conditions here.
When it's for the general population based on something like age, reaching out to everyone seems like it would slow down getting vaccines into people.
 
We still don't have details for medical conditions here.
We have some, a list of eligible conditions and general statement that they are slated in phase 2, but no firm timeline beyond "April". So I (diabetic) just keep watching the health unit eligibility page and monitoring statements from the province and the local medical officer so I don't miss anything.
 
All my grandparents are now booked in things are pretty much backwards though. Youngest grandparent living at home got it done today. The other 2 in group settings Tuesday. My mom is Monday and my Dad books with phase 2A which starts tomorrow but he's at the bottom for booking dates.

AstraZeneca appointments are almost filled.
 
We have some, a list of eligible conditions and general statement that they are slated in phase 2, but no firm timeline beyond "April". So I (diabetic) just keep watching the health unit eligibility page and monitoring statements from the province and the local medical officer so I don't miss anything.
I would have to check I think it was Ontario that changed how immunodeficiencies were considered after pressure from CIPO. Unfortunate how things work at times. I think Alberta is trying to avoid changing the criteria but pushing it close to the booking time. I'm really wondering how well that ends up being. Overall the actual booking is pretty well done here. Certainly problems- the system was down this morning. Looking at the numbers being booked though it's a success and I think the issues at the clinics that had them have been fixed, no news good news type of thing.
 
Hubby was able to book online yesterday and got an appointment for March 31. I was a few months too young.
This morning they announced my age group can book. I got an appointment for March 31.
Time will tell whether there will be shots available at that time.
The location is very close to home
There was no information about what shots we will be getting (could easily be they don't know!).
 
Time will tell whether there will be shots available at that time.
That was Doug Ford's message today. Ontario is apparently capable of getting 4.8 million shots into arms this month, but is only getting 1.4 million doses.

 
Right now 5 countries have banned the astrazeneca vaccine and 6 others have banned the vaccine produced from a certain batch.
Do we know if the vaccines recieved in Canada that suddenly appeared are from these batches or not?
These countries have experienced death or severe blood clotting in some people after getting this vaccine. At this time it is being determined whether this vaccine is directly responsible but in the meantime it is considered safe until proven otherwise. Not a good practice IMO.
 
Right now 5 countries have banned the astrazeneca vaccine and 6 others have banned the vaccine produced from a certain batch.
Do we know if the vaccines recieved in Canada that suddenly appeared are from these batches or not?
These countries have experienced death or severe blood clotting in some people after getting this vaccine. At this time it is being determined whether this vaccine is directly responsible but in the meantime it is considered safe until proven otherwise. Not a good practice IMO.
The countries are all in Europe and as I understand it, the first lots of AstroZeneca received here came from the Indian plant, not the European one, so if it is a batch/lot issue, we are not included. If it is a problem in the vaccine itself, then obviously it applies everywhere.
 
The countries are all in Europe and as I understand it, the first lots of AstroZeneca received here came from the Indian plant, not the European one, so if it is a batch/lot issue, we are not included. If it is a problem in the vaccine itself, then obviously it applies everywhere.
True but we don't know yet where the problem lies and yet they continue giving it.
Also I believe the indian plant was under investigation for the vaccine causing neurological problems.
 
Good article from Global that makes it clear all the suspensions are precautionary and the number of cases seen are so tiny relative to the number of doses given that a relationship is unlikely.


Fortunately, Canada's big shipments of this one are still to come so there's time for the investigations to give us more data.
 
Are you suffering from vaccine envy? I am suffering from vaccine impatience, but not really envious. There are good reasons people are ahead of me.


And I think this one is not paywalled. At least I was still able to access it when I logged out of my Globe account.
 
Are you suffering from vaccine envy? I am suffering from vaccine impatience, but not really envious. There are good reasons people are ahead of me.


And I think this one is not paywalled. At least I was still able to access it when I logged out of my Globe account.
On behalf of my grandparents especially my grandmother who has been in a hospital for months with outbreaks on her ward. I feel like she is someone who should have been in a high priority group. At least she is getting it soon there was concerned she would end up being moved to a facility where most would have received the first already further delaying hers.
 
Are you suffering from vaccine envy? I am suffering from vaccine impatience, but not really envious. There are good reasons people are ahead of me.


And I think this one is not paywalled. At least I was still able to access it when I logged out of my Globe account.
Oh also envy in terms of data. Other than anecdotes within groups nothing is being said about bradykinin angioedema attacks.
 
Can anyone explain what is the difference between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR)?

BROWN: Figure 2 in my article (shown below) sums up all the information you need to know as a layperson. The other calculations in the manuscript are intended for other researchers. You can calculate both relative risk reduction (RRR) and absolute risk reduction (ARR) from the same clinical trial data.

COVID-19-Vaccine-Efficacy.png

On February 26, 2021, the peer-reviewed journal Medicina published another paper by Brown as part of a special issue, “Pandemic Outbreak of Coronavirus.” Brown’s paper, titled “Outcome reporting bias in COVID-19 vaccine clinical trials” is also listed in the U.S. National Library of Medicine of the National Institutes of Health.

In Brown’s first coronavirus paper, he showed how mistaking infection fatality rates for case fatality rates exaggerated the predicted lethality of the SAR-CoV-2 virus. In this second paper, he shows how relative risk reduction measures are being used to exaggerate the efficacy of the COVID-19 vaccines.

Epidemiologist Dr. Ronald B. Brown writes in the paper’s conclusion:

Such examples of outcome reporting bias mislead and distort the public’s interpretation of COVID-19 mRNA vaccine efficacy and violate the ethical and legal obligations of informed consent.
 
BROWN: Figure 2 in my article (shown below) sums up all the information you need to know as a layperson. The other calculations in the manuscript are intended for other researchers. You can calculate both relative risk reduction (RRR) and absolute risk reduction (ARR) from the same clinical trial data.

Is this your article or are you quoting someone else?

Can anyone explain what is the difference between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR)?

I can't
 
Can anyone explain what is the difference between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR)?

BROWN: Figure 2 in my article (shown below) sums up all the information you need to know as a layperson. The other calculations in the manuscript are intended for other researchers. You can calculate both relative risk reduction (RRR) and absolute risk reduction (ARR) from the same clinical trial data.

COVID-19-Vaccine-Efficacy.png

On February 26, 2021, the peer-reviewed journal Medicina published another paper by Brown as part of a special issue, “Pandemic Outbreak of Coronavirus.” Brown’s paper, titled “Outcome reporting bias in COVID-19 vaccine clinical trials” is also listed in the U.S. National Library of Medicine of the National Institutes of Health.

In Brown’s first coronavirus paper, he showed how mistaking infection fatality rates for case fatality rates exaggerated the predicted lethality of the SAR-CoV-2 virus. In this second paper, he shows how relative risk reduction measures are being used to exaggerate the efficacy of the COVID-19 vaccines.

Epidemiologist Dr. Ronald B. Brown writes in the paper’s conclusion:
It's explained within the article:

The percentage of events in the vaccine group is the experimental event rate (EER) or the risk of infection in the vaccine group (1/100 = 1%), and the percentage of events in the placebo group is the control event rate (CER) or the risk of infection in the placebo group (2/100 = 2%). Absolute risk reduction (ARR) is the disease risk difference between the placebo and vaccine groups, i.e., the CER minus the EER (2% − 1% = 1%). The ARR is also known as the vaccine disease preventable incidence (VDPI) [17]. Relative risk reduction (RRR) or vaccine efficacy (VE) is the reduced risk from vaccination, the ARR or VDPI, relative to or divided by the risk in unvaccinated individuals, the CER (1%/2% = 50
 
Can anyone explain what is the difference between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR)?

BROWN: Figure 2 in my article (shown below) sums up all the information you need to know as a layperson. The other calculations in the manuscript are intended for other researchers. You can calculate both relative risk reduction (RRR) and absolute risk reduction (ARR) from the same clinical trial data.

COVID-19-Vaccine-Efficacy.png

On February 26, 2021, the peer-reviewed journal Medicina published another paper by Brown as part of a special issue, “Pandemic Outbreak of Coronavirus.” Brown’s paper, titled “Outcome reporting bias in COVID-19 vaccine clinical trials” is also listed in the U.S. National Library of Medicine of the National Institutes of Health.

In Brown’s first coronavirus paper, he showed how mistaking infection fatality rates for case fatality rates exaggerated the predicted lethality of the SAR-CoV-2 virus. In this second paper, he shows how relative risk reduction measures are being used to exaggerate the efficacy of the COVID-19 vaccines.

Epidemiologist Dr. Ronald B. Brown writes in the paper’s conclusion:
You are still trying to make covid look like a “bad flu”? Look to Brazil, who has let it go rampant. It doesn’t need any further comment.
 
Can a great ado be raised about nothing ... considering what happens when nothing is done?

Nothing was a topic on my grandfather's mind and where it should be properly located ... it may have created a portal for exit!
 
Back
Top